secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001174947-26-000024
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED provides preliminary 2026 guidance at J.P. Morgan Healthcare Conference; no figures in filing
--------------------------------------------------------------------------------

- Presented at J.P. Morgan 44th Annual Healthcare Conference on January 12, 2026.
- Preliminary 2026 financial guidance was included in the investor presentation.
- No specific revenue, EPS, or other guidance figures were disclosed in the filing text.
- Presentation available on CONMED's website under Investors > Presentations.
- CFO Todd W. Garner and CEO Pat J. Beyer presented.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000117494726000024/0001174947-26-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000117494726000024/form8k-35073_cnmd.htm
  HTML page:      https://secwatch.observer/filing/0001174947-26-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer